Global /Taiwan /Healthcare /Medical Devices /6744

Feng Chi Biotech Corp.

6744

• TPEX: 6744 • Delayed

16.60TWD -7%

0.5247 USD

As of 22 June 2026, Feng Chi Biotech Corp. has a market cap of $8.67M USD, ranking #42038 globally and #2328 in Taiwan. It ranks #3721 in the Healthcare sector, and #781 in the Medical Devices industry.

Global Rank

42038

Country Rank

2328

Sector Rank

3721

Industry Rank

781

Key Stats

Market Cap

$8.67MUSD

274.89M TWD

Enterprise Value

$3.23MUSD

102.19M TWD

Revenue (TTM)

$5.59MUSD

177.36M TWD

EBITDA (TTM)

$734.9KUSD

23.25M TWD

Net Income (TTM)

$456.48KUSD

14.47M TWD

EBITDA Margin

13%

Profit Margin

8.2%

PE Ratio

19.0

PS Ratio

1.5

PB Ratio

1.1

EV/EBITDA

3.9

Company Profile

Country (HQ)

Taiwan

Sector

Healthcare

Industry

Medical Devices

CEO

Hong-Ming Zhang open_in_new

Employees

Founded

1992

Website

fcbiotech.com.tw open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-7%	2%	13%	8.5%	-6.5%	0.3%	-2.5%	-42%	-37%

News

Markets

Exchange	Ticker	Price	Quotes
Taipei Exchange (TPEX) MIC: ROCO PRIMARY	6744 豐技生物科技股份有限公司 Ordinary Shares ISIN: TW0006744006 Shares Out.: Shares Outstanding: 14.69M¹ TV: TradingView: TPEX: 6744 SA: Stock Analysis: TPEX: 6744 YF: Yahoo Finance: 6744.TWO GF: Google Finance: TPEX: 6744 BA: Barron's: 6744 MS: Morningstar: ROCO: 6744	16.60 TWD	TV: TradingView: TPEX: 6744 SA: Stock Analysis: TPEX: 6744 YF: Yahoo Finance: 6744.TWO GF: Google Finance: TPEX: 6744 BA: Barron's: 6744 MS: Morningstar: ROCO: 6744

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Feng Chi Biotech Corp.

Feng Chi Biotech Corp. engages in the wholesale and retail of medical equipment and precision instruments and biotechnology services in Taiwan and internationally. The company provides preimplantation genetic testing, prenatal testing, precision medicine, newborn screening, food/pharmaceutical microbiological testing, and medical translational research services. It also distributes various genetic testing technologies and products in oncology. The company was founded in 1992 and is based in Taipei, Taiwan.

Similar Companies

Industry: Medical Devices (Taiwan)

Name	Market Cap (USD) diff.	PE	Country
Sunmax Biotechnology Co., Ltd. TPEX: 4728	$665.59M 21.1B TWD 8K%	29.1	Taiwan
TaiDoc Technology Corp. TWSE: 4736	$375.99M 11.92B TWD 4K%	8.3	Taiwan
United Orthopedic Corp. TPEX: 4129	$301.1M 9.55B TWD 3K%	17.5	Taiwan
Bioteque Corp. TPEX: 4107	$253.52M 8.04B TWD 3K%	15.0	Taiwan
Hi-Clearance Inc. TPEX: 1788	$190.26M 6.03B TWD 2K%	16.4	Taiwan
Formosa Optical Technology Co.,Ltd. TPEX: 5312	$184.3M 5.84B TWD 2K%	15.2	Taiwan

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 2M%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 2M%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 2M%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 1M%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 1M%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 1M%	22.2	Ireland

chevron_leftBack